市場調査レポート

世界のOTC医薬品市場

The World Market for Over The Counter (OTC) Drugs

発行 Kalorama Information 商品コード 243521
出版日 ページ情報 英文 190 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
世界のOTC医薬品市場 The World Market for Over The Counter (OTC) Drugs
出版日: 2012年05月07日 ページ情報: 英文 190 Pages
担当者のコメント
医療系専門の米国の調査会社 Kalorama Information の発行です。幅広い観点から世界市場を分析しています。
概要

多くの製薬会社は、収益拡大と市場拡大をもくろみ、OTC医薬品の開発に機会を見出しています。OTC医薬品はコンビニや食糧品店などで消費者が手にすることができますが、新技術の導入で、オンライン販売やカタログ販売など新たな入手ルートが広がりました。

当レポートでは、世界のOTC医薬品市場について調査し、セグメント別、地域別の売上、市場予測、主要企業のプロファイルと競合動向などをまとめ、概略下記の構成で取り上げております。

第1章 エグゼクティブサマリー

第2章 イントロダクション

  • 背景
  • 米国における販売と安全性問題
  • 消費者への広告とプロモーション
  • 世界の医療と寿命
    • 寿命
    • 出生率
    • 喫煙率
    • 肥満
  • 世界人口の増加率減少
  • 処方薬業界とOTC医薬品業界
  • 経済動向
  • 医療保険問題と動向
  • 消費者問題と動向
  • 専門医療サービスへのアクセスと自己医療との関連性
  • 法規制環境

第3章 アジア太平洋地域およびアフリカにおけるOTC医薬品市場

  • 概要
  • 人口統計
  • OTC医薬品製品セグメント
  • 市場分析
    • OTC医薬品製品セグメント市場分析
    • 国別市場

第4章 欧州におけるOTC医薬品市場

  • 概要
  • 人口統計
  • OTC医薬品製品セグメント
  • 市場分析
    • OTC医薬品製品セグメント市場分析
    • 国別市場

第5章 北米におけるOTC医薬品市場

  • 概要
  • 人口統計
  • OTC医薬品製品セグメント
  • 市場分析
    • OTC医薬品製品セグメント市場分析
    • 国別市場

第6章 南米におけるOTC医薬品市場

  • 概要
  • 人口統計
  • OTC医薬品製品セグメント
  • 市場分析
    • OTC医薬品製品セグメント市場分析
    • 国別市場

第7章 世界のOTC医薬品市場サマリー

  • 概要
    • OTC医薬品製品セグメント市場分析
    • 国別市場

第8章 主な製造業者

  • 概要
  • 競合分析
  • 重要な契約、合併、買収
  • 主要企業プロファイル
    • Bayer Healthcare Ag
    • Boehringer Ingelheim GmbH
    • GlaxoSmithKline
    • MC Neil Consumer
    • Merck
    • Novartis Consumer
    • Pfizer
    • Procter & Gamble
    • Reckitt Benckiser
    • Sanofi
    • 大正製薬

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: KLI6923618

Abstract

Over-the-counter (OTC), non-legend, and non-prescription are all adjectives describing drugs that an individual may purchase without a prescription. Many pharmaceutical companies seeking more revenue and international exposure have found an opportunity in the development of over-the-counter (OTC) drugs. OTC drugs are sold to consumers by convenience and grocery stores. However, new technology has allowed a new range of outlets including online sales and catalog. Drugs included in OTC segments are pain relievers, cough and cold remedies, sleeping aids, antifungals, and other products approved for use as a self-medication product.

For the purpose of this study, Kalorama Information has divided products into five general segments:

  • Analgesics
  • Allergy, Cough, Cold, Flu Remedies
  • Gastrointestinal Remedies
  • Dermatologics
  • Others, including:
    • Smoking cessation products
    • Sleepaids
    • Hair growth remedies
    • Diet aids

Revenues for each segment were generated using dollar and unit sales for key products in each segment and region. The report provides examples of OTC drugs in each general region, segmented as follows:

  • Asia Pacific and Africa
  • Europe
  • North America
  • South America

The report includes incidence of conditions which are often treated with OTC medicines, health statistics related to the industry, birth rates, world population, populations by region and issues affecting the market as a whole. Information is presented as a worldwide overview, with special emphasis on the U.S., Japan, Germany, and other key markets. The market segments provide an overview of demographics, overview of products available in each region, market estimates and forecasts. Additionally, a competitive analysis of leading providers and profiles of providers is covered.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 50 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers' level. The base year for data was 2011. Historical data was provided for the years 2007 through 2010, with forecast data provided for 2012 through 2015. Compound annual growth rates (CAGRs) are provided for the 2007-2011 and 2011-2015 periods for each region and/or segment covered. Competitive analysis is provided for the year 2011 with some reference for 2009 and 2010. The forecasted market analysis for 2011-2015 was largely based on demographic trends, new developments, and global expansion.

Additional Information

Of the many developments in the Over the Counter Drug market noted by Kalorama Information in this report, there has been a notable increased interest in consumer care divisions by leading companies such as Sanofi andBoehringer Ingelheim. The switch of Allegra to OTC was an important strategic move forSanofi and one of the key reasons for the purchase of Chattem in 2009.

Boehringer Ingelheim also expanded its investment in OTC with the creation ofRx-to-OTC switch unit in 2010, increasing global expansion--specifically inAsian markets, and new OTC product introductions in categories with limitedtreatments. More details on these types of developments at these and other companies are covered in this report.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

  • Background
  • Scope and Methodology
  • Size and Growth of the Market
  • Key Issues and Trends Affecting Market
  • Leading Competitors

CHAPTER TWO: INTRODUCTION

  • Background
  • Distribution and Safety Issues in the United States
  • Consumer Advertising/Promotion
  • World Health and Life Expectancy
    • Life Expectancy
    • Birth Rates
    • Tobacco Use
    • Obesity
  • Declining Growth of the World Population
  • Prescription vs. Over-the-Counter Industry
    • Rx-to-OTC Switch Industry
    • Rx-to-OTC Switch Forecast in the United States
  • Economic Trends
    • Purchasing Power Trends
    • U.S. Healthcare Market
    • U.S. Healthcare Challenges
  • Health Insurance Issues and Trends
    • Healthcare Flexible Spending Accounts and OTC Medicines
  • Consumer Issues and Trends
    • U.S Consumers
    • Consumers Around the World
  • Access to Professional Medical Services and the Link to Self-Medication
    • Online Resources for Health Information
  • Regulatory Environment
    • Revisions to Pharmaceutical Affairs Law (PAL) in Japan
    • Russian Beneficiary Drug Provision Program
    • A Third Class of Drugs in the United States

CHAPTER THREE: OTC MARKETS IN ASIA-PACIFIC AND AFRICA

  • Overview
  • Demographics
  • OTC Product Segments
  • Market Analysis
    • OTC Product Segment Market Analysis
    • Markets by Country

CHAPTER FOUR: OTC MARKETS IN EUROPE

  • Overview
  • Demographics
  • OTC Product Segments
  • Market Analysis
    • OTC Product Segment Market Analysis
    • Markets by Country

CHAPTER FIVE: OTC MARKETS IN NORTH AMERICA

  • Overview
  • Demographics
  • OTC Product Segments
  • Market Analysis
    • OTC Product Segment Market Analysis
    • Markets by Country

CHAPTER SIX: OTC MARKETS IN SOUTH AMERICA

  • Overview
  • Demographics
  • OTC Product Segments
  • Market Analysis
    • OTC Product Segment Market Analysis
    • Markets by Country

CHAPTER SEVEN: SUMMARY OF WORLD OTC MARKETS

  • Overview
    • OTC Product Segment Market Analysis
    • Markets by Country

CHAPTER EIGHT: LEADING OTC MANUFACTURERS

  • Overview
  • Competitor Analysis
  • Significant Agreements, Mergers and Acquisitions
    • Procter & Gamble and Teva Pharmaceutical Industries
    • Sanofi and Chattem Consumer
    • Schering-Plough and Merck & Co.
    • Wyeth and Pfizer
    • Reckitt Benckiser and Adams Respiratory Therapeutics
    • Bristol-Myers Squibb and Novartis AG
    • Johnson & Johnson and Pfizer
    • Reckitt Benckiser and Boots Healthcare
    • Bayer and Roche
  • Leading Corporate Profiles
    • Bayer Healthcare Ag
    • Boehringer Ingelheim Gmbh
    • Glaxosmithkline
    • Mc Neil Consumer
    • (A Johnson & Johnson Company)
    • Merck
    • Novartis Consumer
    • Pfizer
    • Procter & Gamble
    • Reckitt Benckiser
    • Sanofi
    • Taisho Pharmaceutical

APPENDIX: LIST OF MAJOR COMPANIES

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Table 1-1 5: Total World OTC Market Analysis, 2007-2015
  • Figure 1-1 : Total World OTC Market Analysis: 2007-2015

CHAPTER TWO: INTRODUCTION

  • Table 2-1 : Average Life Expectancy in Years by Country 1980, 2004 and 2011
  • Figure 2-1 : Average Life Expectancy in Years by Country 1980 and 2011
  • Table 2-2 : Crude Birth Rate per 1,000 Persons 2000, 2005 and Projected 2012 and 2020
  • Table 2-3 : Percent of Smokers by Country
  • Figure 2-2 : Average Percent of Smokers Worldwide in Developed Regions
  • Table 2-4 : Percent of Obese* Population, 2008
  • Table 2-5 : World Population 1980 to 2050
  • Figure 2-3 : World Population 1980 to 2050
  • Table 2-6 : Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Country, 2011
  • Figure 2-4 : Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Country, 2011
  • Table 2-7 : Leading FDA Approved Rx-to-OTC Switches, 1994-2011
  • Figure 2-5 : Number of New Rx-to-OTC Switches in the United States, per Year 1976-2011
  • Table 2-8
  • Table 2-9 : Potential Rx-to-OTC Switches, 2012-2015
  • Table 2-9 : P otential Rx-to-OTC Switches, 2012-2015
  • Table 2-10 : Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000 and 2009
  • Figure 2-6 : Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000, and 2006
  • Table 2-11 : Gross National Income Comparison by Country 2000-2010
  • Figure 2-7 : Gross National Income Growth by Country 2000-2010
  • Table 2-12 : National Healthcare Expenditures in the United States 1960-2015
  • Figure 2-8 : Healthcare Spending as a Percent of GDP in the United States
  • Table 2-13 : Health Insurance Trends in the United States 2005-2009
  • Table 2-14 : Practicing Physicians per 1,000 Population by Country, 2000-2008
  • Figure 2-9 : Internet Users per 100 Inhabitants, 2010
  • Figure 2-10 : Typical Pharmacist-Consumer OTC Drug Counseling Session

CHAPTER THREE: OTC MARKETS IN ASIA-PACIFIC AND AFRICA

  • Table 3-1 : Total Midyear Population by the Five Most Populated Countries in Asia-Pacific, 2005-2025
  • Figure 3-1 : Total Midyear Population by the Five Most Populated Countries in Asia-Pacific, 2005, 2015, and 2025
  • Table 3-2 : Total Midyear Population in Africa by Region, 1995-2025
  • Figure 3-2 : Total Midyear Population for Africa by Region, 2005, 2015, and 2025
  • Table 3-3 : Examples of Marketed OTC Products in Asia-Pacific and Africa (Product Name by Type and Marketer)
  • Table 3-4 : Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2007, 2011 and 2015
  • Figure 3-3 : Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2011
  • Figure 3-4 : Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2015
  • Table 3-5 : Asia-Pacific/Africa OTC Market Analysis, 2007-2015
  • Figure 3-5 : Asia-Pacific/Africa OTC Market Analysis: 2007-2015
  • Table 3-6 : Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2007-2015
  • Figure 3-6 : Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2007-2015
  • Figure 3-7 : Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2011
  • Table 3-7 : Asia-Pacific/Africa OTC Market Analysis by Selected Country, 2011
  • Figure 3-8 : Asia-Pacific/Africa OTC Market Analysis by Selected Country, 2011

CHAPTER FOUR: OTC MARKETS IN EUROPE

  • Table 4-1 : Total Midyear Population by the Five Most Populated Countries in Europe, 2005-2025
  • Figure 4-1 : Total Midyear Population by the Five Most Populated Countries in Europe, 2005, 2015, and 2025
  • Table 4-2 : Examples of Marketed OTC Products in Europe (Product Name by Type and Marketer)
  • Table 4-3 : European OTC Market as a Percentage of World Market, 2007, 2011 and 2015
  • Figure 4-2 : European OTC Market as a Percentage of World Market, 2011
  • Figure 4-3 : European OTC Market as a Percentage of World Market, 2015
  • Table 4-4 : European OTC Market Analysis, 2007-2015
  • Figure 4-4 : European OTC Market Analysis: 2007-2015
  • Table 4-5 : European OTC Market Analysis, Markets by Product Segment, 2007-2015
  • Figure 4-5 : European OTC Market Analysis, Markets by Product Segment, 2007-2015
  • Figure 4-6 : European OTC Market Analysis by Product Segment, 2011
  • Table 4-6 : European OTC Market Analysis by Selected Country, 2011
  • Figure 4-7 : European OTC Market Analysis by Selected Country, 2011

CHAPTER FIVE: OTC MARKETS IN NORTH AMERICA

  • Table 5-1 : Total Midyear Population by the Five Most Populated Countries in North America, 2005-2025
  • Figure 5-1 : Total Midyear Population by the Five Most Populated Countries in North America, 2005, 2015, and 2025
  • Table 5-2 : Examples of Marketed OTC Products in North America (Product Name by Type and Marketer)
  • Table 5-3 : North American OTC Market as a Percentage of World Market, 2007, 2011 and 2015
  • Figure 5-2 : North American OTC Market as a Percentage of World Market, 2011
  • Figure 5-3 : North American OTC Market as a Percentage of World Market, 2015
  • Table 5-4 : North American OTC Market Analysis, 2007-2015
  • Figure 5-4 : North American OTC Market Analysis: 2007-2015
  • Table 5-5 : North American OTC Market Analysis by Product Segment, 2007-2015
  • Figure 5-5 : North American OTC Market Analysis by Product Segment, 2007-2015
  • Figure 5-6 : North American OTC Market Analysis by Product Segment, 2011
  • Table 5-6 : North American OTC Market Analysis by Selected Country, 2011
  • Figure 5-7 : North American OTC Market Analysis by Selected Country, 2011

CHAPTER SIX: OTC MARKETS IN SOUTH AMERICA

  • Table 6-1 : Total Midyear Population by the Five Most Populated Countries in South America, 2005-2025
  • Figure 6-1 : Total Midyear Population by the Five Most Populated Countries in South America, 2005, 2015, and 2025
  • Table 6-2 : Examples of Marketed OTC Products in South America (Product Name by Type and Marketer)
  • Table 6-3 : South American OTC Market as a Percentage of World Market, 2007, 2011 and 2015
  • Figure 6-2 : South American OTC Market as a Percentage of World Market, 2011
  • Figure 6-3 : South American OTC Market as a Percentage of World Market, 2015
  • Table 6-4 : South American OTC Market Analysis, 2007-2015
  • Figure 6-4 : South American OTC Market Analysis: 2007-2015
  • Table 6-5 : South American OTC Market Analysis by Product Segment, 2007-2015
  • Figure 6-5 : South American OTC Market Analysis by Product Segment, 2007-2015
  • Figure 6-6 : South American OTC Market Analysis by Product Segment, 2011
  • Table 6-6 : South American OTC Market Analysis by Selected Country, 2011
  • Figure 6-7 South American OTC Market Analysis by Selected Country, 2011

CHAPTER SEVEN: SUMMARY OF WORLD OTC MARKETS

  • Table 7-1 : Total World OTC Market Analysis, 2007-2015
  • Figure 7-1 : Total World OTC Market Analysis: 2007-2015
  • Table 7-2 : Total World OTC Market Analysis, Markets by Product Segment, 2007-2015
  • Figure 7-2 : Total World OTC Market Analysis, Markets by Product Segment, 2007-2015
  • Figure 7-3 : Total World OTC Market Analysis by Product Segment, 2011
  • Figure 7-4 : Total World OTC Market Analysis by Product Segment, 2015
  • Table 7-3 : Top Ten World OTC Markets by Country, 2011
  • Figure 7-5 : Top Ten World OTC Markets by Country, 2011

CHAPTER EIGHT: LEADING OTC MANUFACTURERS

  • Table 8-1 : Leading Suppliers Shares of the OTC Market by Estimated Revenues - 2009, 2010 and 2011
  • Figure 8-1 : Leading Suppliers Shares of the OTC Market, 2009
  • Figure 8-2 : Leading Suppliers Shares of the OTC Market, 2010
  • Figure 8-3 : Leading Suppliers Shares of the OTC Market, 2011
Back to Top